RT Journal Article
SR Electronic
T1 Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.19.20215426
DO 10.1101/2020.10.19.20215426
A1 Chua, Felix
A1 Vancheeswaran, Rama
A1 Draper, Adrian
A1 Vaghela, Tejal
A1 Knight, Matthew
A1 Mogal, Rahul
A1 Singh, Jaswinder
A1 Spencer, Lisa G
A1 Thwaite, Erica
A1 Mitchell, Harry
A1 Calmonson, Sam
A1 Mahdi, Noor
A1 Assadullah, Shershah
A1 Leung, Matthew
A1 O’Neill, Aisling
A1 Popat, Chayya
A1 Kumar, Radhika
A1 Humphries, Thomas J
A1 Talbutt, Rebecca
A1 Raghunath, Sarika
A1 Molyneaux, Philip L
A1 Schechter, Miriam
A1 Lowe, Jeremy
A1 Barlow, Andrew
YR 2020
UL http://medrxiv.org/content/early/2020/10/21/2020.10.19.20215426.abstract
AB Introduction Risk factors of adverse outcomes in COVID-19 are defined but stratification of mortality using non-laboratory measured scores, particularly at the time of pre-hospital SARS-CoV-2 testing, is lacking.Methods Multivariate regression with bootstrapping was used to identify independent mortality predictors in a derivation cohort of COVID-19 patients. Predictions were externally validated in a large random sample of the ISARIC cohort (N=14,231) and a smaller cohort from Aintree (N=290).Results 983 patients (median age 70, IQR 53-83; in-hospital mortality 29.9%) were recruited over an 11-week study period. Through sequential modelling, a 5-predictor score termed SOARS (SpO2, Obesity, Age, Respiratory rate, Stroke history) was developed to correlate COVID-19 severity across low, moderate and high strata of mortality risk. The score discriminated well for in-hospital death, with area under the receiver operating characteristic values of 0.82, 0.80 and 0.74 in the derivation, Aintree and ISARIC validation cohorts respectively. Its predictive accuracy (calibration) in both external cohorts was consistently higher in patients with milder disease (SOARS 0-1), the same individuals who could be identified for safe outpatient monitoring. Prediction of a non-fatal outcome in this group was accompanied by high score sensitivity (99.2%) and negative predictive value (95.9%).Conclusion The SOARS score uses constitutive and readily assessed individual characteristics to predict the risk of COVID-19 death. Deployment of the score could potentially inform clinical triage in pre-admission settings where expedient and reliable decision-making is key. The resurgence of SARS-CoV-2 transmission provides an opportunity to further validate and update its performance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was provided by Stanmore Research Ethics Committee, London, England (IRAS ID: 283888). The study is registered with the National Health Service Health Research Authority under the reference 20/HRA/2344.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData sharing De-identified data can be shared on request after publication of the manuscript. Requests to be forwarded to ORCID ID: 0000-0001-7845-0173 (F.chua@rbht.nhs.uk)